U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 214216
Company: MACLEODS PHARMS LTD
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE 200MG;EQ 25MG BASE TABLET;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
04/07/2026 ORIG-1 Approval STANDARD Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/214216Orig1s000TAltr.pdf

EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE

TABLET;ORAL; 200MG;EQ 25MG BASE
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
DESCOVY EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE 200MG;EQ 25MG BASE TABLET;ORAL Prescription Yes AB 208215 GILEAD SCIENCES INC
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE 200MG;EQ 25MG BASE TABLET;ORAL Prescription No AB 213926 LUPIN LTD
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE 200MG;EQ 25MG BASE TABLET;ORAL Prescription No AB 214216 MACLEODS PHARMS LTD
Back to Top